Skip to main navigation Skip to search Skip to main content

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols

  • Isidro B. Salusky
  • , William G. Goodman
  • , Shobha Sahney
  • , Barbara Gales
  • , Ashley Perilloux
  • , He Jing Wang
  • , Robert M. Elashoff
  • , Harald Jüppner

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2501-2508
Number of pages8
JournalJournal of the American Society of Nephrology
Volume16
Issue number8
DOIs
StatePublished - Aug 2005

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • Prospective Studies
  • Blood Chemical Analysis
  • Sterols/metabolism
  • Humans
  • Child, Preschool
  • Infant
  • Male
  • Bone Diseases/chemically induced
  • Calcitriol/administration & dosage
  • Polyamines/pharmacology
  • Time Factors
  • Adult
  • Female
  • Ergocalciferols/administration & dosage
  • Sevelamer
  • Calcium/blood
  • Child
  • Vitamin D/metabolism
  • Bone and Bones/drug effects
  • Calcium Carbonate/metabolism
  • Parathyroid Hormone/adverse effects
  • Treatment Outcome
  • Alkaline Phosphatase/blood
  • Analysis of Variance
  • Biopsy
  • Adolescent
  • Protein Binding
  • Longitudinal Studies

Cite this